Fundraising FoxMethuselah Funds — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
WinSanTorwinsantor.comin𝕏May 2017
Winsantor is a clinical-stage biotechnology company developing treatments for peripheral neuropathies, including diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy.
BiotechHealthtechMedical DevicesSan Diego, US
Stan Kim(Executive Officer, Director)inNigel Calcutt(Director)
Co-investorsThynk Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.